Our Message to You

Every single day, we dedicate ourselves to achieving excellence in our work. Our mission is to advance our product candidates swiftly and efficiently, targeting patient populations with limited or no treatment options. At Cellectar, many of us have personally experienced the devastating impact of cancer on our own lives and the lives of our loved ones. Some of us have lost close relatives to the very cancers we are now studying in our clinical trials.

These personal experiences fuel our passion, drive, and determination to develop safe and effective treatments for cancer patients worldwide. Whether you are a 7-year-old child diagnosed with neuroblastoma or a 70-year-old adult facing Multiple Myeloma, our commitment to you remains unwavering. We strive to ensure your safety, enhance your quality of life during treatment, and most importantly, support your journey to recovery.

To learn more about our clinical studies or to learn more about our Waldenstrom’s macroglobulinemia pivotal clinical study, please visit our Clinical Studies page or visit

Clinical Studies Overview

Clinical studies are a fundamental necessity in the development and advancement of new treatment options for battling cancer, and you may not know it, but you could play an important role. Clinical studies need patients to participate so that they can advance through the processes necessary to potentially get a new treatment to market. Your participation in clinical studies can help create a better treatment landscape for future cancer patients.

To a lot learn more about clinical studies in general, please visit and find the Clinical Studies section.

Disease Education and Patient Resources

Once you or your loved one has been diagnosed with cancer, it is essential that you learn as much as you can about the disease; this will help you make better treatment decisions. We believe in empowering patients and caregivers with both information and resources. To this end, we have assembled disease education and patient resource sections for each of the cancers included in our clinical studies and have listed them below. For more information on the cancers listed below, as well as many others, please visit

Waldenstrom’s macroglobulinemia

Multiple Myeloma

Pediatric and Adolescent Cancers